molsidomine Tablets 2 mg, 4 mg

Established in 2011, this GMP manufacturer is a CTD dossier owner and manufacturer, focusing on the development and production of specialized pharmaceuticals for cardiovascular diseases and rheumatoid arthritis. Operating a state-of-the-art facility in Hwaseong, South Korea, the manufacturer adheres to international GMP standards. As a CTD dossier owner and manufacturer, it maintains a dedicated team of 47 employees, committed to innovation and excellence in the pharmaceutical industry.